Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 3
1(14.3%)
7Total
N/A(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07397156Completed

Long-Term Outcomes After ICU-Treated COVID-19 ARDS

Role: lead

NCT05527704Phase 3Active Not Recruiting

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Role: collaborator

NCT06259136Not ApplicableRecruiting

Palliative Care Yields Cancer Wellbeing Support

Role: collaborator

NCT06726044Not ApplicableCompleted

Effectiveness of Rehabilitation After Arthroscopic ACL Reconstruction Using Inertial Exercises

Role: lead

NCT06584266Recruiting

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

Role: lead

NCT06361628Not ApplicableNot Yet Recruiting

Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine

Role: collaborator

NCT05672641Not ApplicableCompleted

Is Inertial Training More Effective Than Conventional Strength Training?

Role: lead

NCT04808765Not ApplicableUnknown

Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction

Role: lead

NCT04621942Not ApplicableCompleted

Inertial Rehabilitation in Women After Mastectomy

Role: lead

NCT02758678Completed

Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients

Role: collaborator

All 10 trials loaded